Schneider Eugene Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
8
Insider Sells Sum
$2.6M

Insider Activity of Schneider Eugene

According to the SEC Form 4 filings, Schneider Eugene, being in a position of

  1. EVP, Chf Clinical Develop Ofcr at Ionis Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 47293 shares for $3.74M,
    over all time since 2023-01-18, has bought 0 shares, and sold 131260 shares for $7.95M.

Biography of Schneider Eugene

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$3,738,4504100

Comparison of Insiders on Amount of Buys and Sells

2026-06-26SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chf Clinical Develop Ofcr
26,000
0.0157%
$81.05$2.11M-33.11%
2026-03-19SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chf Clinical Develop Ofcr
5,812
0.0035%
$70.97$412,486-12.74%
2026-01-30SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chf Clinical Develop Ofcr
6,179
0.0039%
$83.45$515,630-12.28%
2026-01-16SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chf Clinical Develop Ofcr
9,302
0.0057%
$75.59$703,138-4.13%
2025-09-03SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chf Clinical Develop Ofcr
19,658
0.0124%
$60.81$1.2M+22.84%
2025-08-04SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chf Clinical Develop Ofcr
9,549
0.006%
$42.80$408,701+71.02%
2025-01-31SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chf Clinical Develop Ofcr
1,484
0.0009%
$32.20$47,780+33.28%
2025-01-16SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chf Clinical Develop Ofcr
6,523
0.0042%
$32.79$213,889+29.55%
2024-02-02SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chf Clinical Develop Ofcr
2,106
0.0014%
$49.59$104,437-17.35%
2024-01-17SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chf Clinical Develop Ofcr
5,482
0.0038%
$50.42$276,386-18.42%
2024-01-12SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chf Clinical Develop Ofcr
8,000
0.0056%
$53.50$427,999-21.5%
2023-12-26SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chf Clinical Develop Ofcr
25,000
0.0174%
$51.46$1.29M-17.08%
2023-02-06SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chf Clinical Develop Ofcr
1,413
0.001%
$40.67$57,464+1.9%
2023-01-18SaleIonis Pharmaceuticals, Inc.
IONS
EVP, Chf Clinical Develop Ofcr
4,752
0.0033%
$39.57$188,052+2.76%
Total: 14
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.